- Home
- TPST vs RMTI Comparison
TPST vs RMTI Comparison
Compare TPST & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPST | RMTI |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | United States |
| Employees | N/A | 300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 32.9M |
| IPO Year | 2012 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TPST | RMTI |
|---|---|---|
| Price | $1.77 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $11.00 | $2.00 |
| AVG Volume (30 Days) | 126.5K | ★ 243.6K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $295,000.00 | ★ $69,258,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $0.74 |
| 52 Week High | $12.22 | $2.10 |
Technical Indicators
Market Signals| Indicator | TPST | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 34.90 |
| Support Level | $1.57 | N/A |
| Resistance Level | $2.15 | $1.00 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 11.91 | 14.73 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.